Neuberger Berman Group LLC Has $14.04 Million Holdings in Relx Plc $RELX

Key Points

• Neuberger Berman Group LLC has increased its holdings in RELX PLC by 8.7%, acquiring an additional 22,249 shares, bringing its total ownership to 279,344 shares valued at approximately $14 million.
• Analysts have rated the stock positively, with a consensus rating of "Buy", following a rating upgrade from Wall Street Zen.
• RELX recently declared a semi-annual dividend of $0.2634 per share, despite cutting its overall dividend payout ratio to 28.49%.

Neuberger Berman Group LLC lifted its holdings in Relx Plc (NYSE:RELX - Free Report) by 8.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 279,344 shares of the technology company's stock after buying an additional 22,249 shares during the period. Neuberger Berman Group LLC's holdings in Relx were worth $14,043,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Ameriprise Financial Inc. increased its position in shares of Relx by 368.7% during the fourth quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company's stock valued at $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company's stock valued at $99,542,000 after purchasing an additional 745,532 shares in the last quarter. GAMMA Investing LLC grew its holdings in Relx by 6,125.5% during the 1st quarter. GAMMA Investing LLC now owns 679,073 shares of the technology company's stock worth $34,232,000 after acquiring an additional 668,165 shares in the last quarter. Carnegie Investment Counsel acquired a new position in Relx during the 1st quarter worth approximately $16,026,000. Finally, Bank of America Corp DE lifted its position in shares of Relx by 4.2% during the 4th quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock worth $283,714,000 after buying an additional 253,107 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded shares of Relx from a "hold" rating to a "buy" rating in a research report on Saturday, July 26th. One analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy".

Relx Stock Down 0.1%

NYSE:RELX traded down $0.0250 during trading hours on Tuesday, hitting $47.7950. The stock had a trading volume of 1,295,064 shares, compared to its average volume of 858,104. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. Relx Plc has a 1-year low of $44.19 and a 1-year high of $56.33. The business has a 50 day simple moving average of $52.07 and a two-hundred day simple moving average of $51.55. The company has a market cap of $87.68 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 3.13 and a beta of 0.88.

Relx Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Stockholders of record on Friday, August 8th will be issued a dividend of $0.2634 per share. The ex-dividend date of this dividend is Friday, August 8th. This represents a dividend yield of 170.0%. Relx's payout ratio is 27.96%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.